Tremfya was administered subcutaneously for both induction and maintenance, inducing a clinical response in 65% of moderate ...

Ex-Takeda VP Tauhid Ali, Ph.D., with broad leadership and drug development experience becomes Board DirectorSeasoned regulatory strategist Darren Rubin becomes VP, Amalive, heading development of the ...

The Bombay high court permitted an 18-year-old rape survivor to terminate her 28-week pregnancy, upholding her right to choice and autonomy.